
Clinrol has been shortlisted for not one but three awards in this year’s Finder Innovation Awards. Clinrol has placed as a finalist in the ‘Tech’, ‘B2B’ and ‘AI’ Innovation categories for its use of AI to transform patient recruitment for clinical trials.
The Finder Innovation Awards is an annual search for the most innovative individuals, teams and brands in Australia. Now in its ninth year, the awards cover 19 categories including banking and lending, retail, among others.
The Best Tech Innovation category is designed to celebrate the most disruptive tech innovation in Australia while the B2B Innovation category is open to companies offering innovative solutions for businesses. The AI Innovation category shines a spotlight on the companies using AI to make their businesses more efficient while helping to solve real-world issues.
Clinrol impressed the judges in all three categories and is in the running to take home gold later this month.
Its AI-driven recruitment platform leverages advanced machine learning algorithms to match patients with the most suitable clinical trials based on their medical history, genetic information, and real-time health data.
While many companies are yet to fully integrate AI into their operations, Clinrol has incorporated the technology at the core of its patient recruitment platform with impressive results for clinics and patients alike.
Patients now have a seamless and user-friendly way to discover clinical trials. Meanwhile, clinics benefit from improved recruitment efficiency and higher-quality patient matches. A true win-win.
With so much chatter around AI it’s exciting to see companies applying the technology to improve real-world outcomes. Clinrol’s early adoption of AI is well-deserving of its place in this year’s Finder Innovation Awards.
For more information on Finder Awards
visit the Finder Innovation Awards homepage.
Share